Plasma lipidomics reveals potential lipid markers of major depressive disorder
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) is a grave debilitating mental disease with a high incidence and severely impairs quality of life. Therefore, its physiopathological basis study and diagnostic biomarker discovery are extremely valuable. In this study, a non-targeted lipidomics strategy using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was performed to reveal differential lipids between MDD (n = 60) and healthy controls (HCs, n = 60). Validation of changed lipid species was performed in an independent batch including 75 MDD and 52 HC using the same lipidomic method. Pronouncedly changed lipid species in MDD were discovered, which mainly were lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 1-O-alkyl-2-acyl-PE (PE O), 1-O-alkyl-2-acyl-PC (PC O), sphingomyelin (SM), diacylglycerol (DG), and triacylglycerol (TG). Among these lipid species, LPC, LPE, PC, PE, PI, TG, etc. remarkably increased in MDD and showed pronounced positive relationships with depression severity, while 1-O-alkyl-2-acyl-PE and SM with odd summed carbon number significantly decreased in MDD and demonstrated negative relationships with depression severity. A combinational lipid panel including LPE 20:4, PC 34:1, PI 40:4, SM 39:1, 2, and TG 44:2 was defined as potential diagnostic biomarker with a good sensitivity and specificity for distinguishi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These clinical data suggest that sex differences in MDD may result from differences in OS and lipid metabolism, but further research is required to make this connection.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [458]
In the citing paper
“as 1-Oalkyl-2-acyl-PEs levels are decreased in MDD, showing a negative correlation with the extent of depression, lysophospholipid (LPC) and phospholipid (PC) levels are increased in MDD, exhibiting a substantial positive correlation with depression severity. 458”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [458]
In the citing paper
“Several studies have indicated an association between the lipid concentrations of octadecyl-phosphatidylethanolamine (PE-O) [58], SM, and PC-O [63] and symptom severity according to the specific scales.”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [58]
In the citing paper
“Thus, lipid related metabolites have also been suggested to be involved in the pathophysiology of MDD (Liu et al., 2016;Parekh et al., 2017;Shelton and Miller, 2010).”
From Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study (2018) · cites this paper as Liu et al., 2016
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“MDD, with its high incidence, has affected a wide range of people by giving rise to severe impairments in quality of life [1, 2].”
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Clinical diagnosis of depression in primary care: a meta-analysis
Mitchell, A. J., Vaze, A., & Rao, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60879-5 · Cited by 1,251 · cited 1×
“What is more, at present, MDD diagnosis solely depends on symptom and clinical manifestation, and current diagnostic methods lead to a high misdiagnosis rate [6].”
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Slusarski, D. C., Corces, V. G., & Moon, R. T. (1997) · Nature · doi:10.1038/37138 · Cited by 680 · cited 1×
“PI, a kind of phospholipid, worked as downstream effectors in G-protein linked signaling system (GPLS) [34].”
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
Depression as an Antecedent to Heart Disease Among Women and Men in the NHANES I Study
Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J., & Moeschberger, M. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1261 · Cited by 490
Uher, R., Payne, J. L., Pavlova, B., & Perlis, R. H. (2014) · Depression and Anxiety · doi:10.1002/da.22217 · Cited by 456 · cited 1×
“Mental Disorders criteria for MDD (DSM-IV) were adopted to diagnose MDD patients in our study [23].”
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“458 Similarly, a study found that men and women had different lipid concentrations.”
BackgroundBiomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Zheng, P., Wu, J., Zhang, H., Perry, S. W., Yin, B., Tan, X., Chai, T., Liang, W., Huang, Y., Li, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0744-2 · Cited by 205
Self-citationPeripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Amin, N., Liu, J., Bonnechère, B., MahmoudianDehkordi, S., Arnold, M., Batra, R., Chiou, Y., Fernandes, M., Ikram, M. A., Kraaij, R., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0685 · Cited by 167
Metadata
- Authors
- Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Corresponding author
- Xie, Peng
- Xu, Guowang
- ORCID
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2016-07-25
- Volume
- 408
- Issue
- 23
- Pages
- 6497-6507
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- OpenAlex
- W2496213445
- Cited by
- 148
- References
- 42
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 25 · 2023: 20 · 2022: 16 · 2021: 12 · 2020: 13 · 2019: 9 · 2018: 10 · 2017: 5
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Analytical and Bioanalytical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Dalian Institute of Chemical Physics, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (81401140)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, plasma lipidomics, diagnostic biomarkers, lipid species, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, sphingomyelin, diacylglycerol, triglycerides, depression severity, lipid metabolism disorders
- MeSH terms
- Adult, Chromatography, High Pressure Liquid, Major Depressive Disorder, Female, Humans, Lipids, Male, Middle Aged, Quality of Life, Sensitivity and Specificity, Mass Spectrometry, Biomarkers, Lipid Metabolism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma lipidomics reveals potential lipid markers of major depressive disorder. https://app.cochat.ai/papers/10.1007/s00216-016-9768-5
- The paper
- Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016). Plasma lipidomics reveals potential lipid markers of major depressive disorder. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-016-9768-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.